Nitto Denko (OTCMKTS:NDEKY) vs. Sandoz Group (OTCMKTS:SDZNY) Financial Survey

Sandoz Group (OTCMKTS:SDZNY) and Nitto Denko (OTCMKTS:NDEKY) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Analyst Ratings

This is a summary of current recommendations and price targets for Sandoz Group and Nitto Denko, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sandoz Group	0	3	0	0	2.00
Nitto Denko	0	0	0	0	0.00

Profitability

This table compares Sandoz Group and Nitto Denko’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sandoz Group	N/A	N/A	N/A
Nitto Denko	12.91%	12.60%	9.90%

Risk and Volatility

Sandoz Group has a beta of 0.2, meaning that its share price is 80% less volatile than the S&P 500. Comparatively, Nitto Denko has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500.

Insider & Institutional Ownership

0.1% of Sandoz Group shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Sandoz Group and Nitto Denko”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sandoz Group	$9.65 billion	1.90	$77.00 million	N/A	N/A
Nitto Denko	$6.34 billion	2.16	$708.49 million	N/A	N/A

Nitto Denko has lower revenue, but higher earnings than Sandoz Group.

Dividends

Sandoz Group pays an annual dividend of $0.40 per share and has a dividend yield of 1.0%. Nitto Denko pays an annual dividend of $0.25 per share and has a dividend yield of 1.3%.

Summary

Nitto Denko beats Sandoz Group on 7 of the 10 factors compared between the two stocks.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

About Nitto Denko

Nitto Denko Corporation primarily engages in the adhesive tapes business in Japan, the Americas, Europe, Asia, and Oceania. It provides double sided tapes, surface protective films, sealing materials, masking tapes, membranes, FPD/touch panel related products, gasket materials, semiconductor manufacturing process products, flexible printed circuit boards, porous films/breathable materials, and packaging tapes. The company also offers functional thermal transfer systems, such as labels, barcode label printers, and label printing software; tapes for electrical and electronic equipment; dust removal products for clean rooms; fluoroplastic sheets and tapes, and fluoroplastic porous films; and materials for housing and construction. In addition, it provides medical products, including transdermal therapeutic systems, athletic tapes, medical adhesive tapes for wearable devices and body sensors, adhesive tapes, and particles for nucleic acid synthesis. The company offers its products to automotive and transportation, housing/housing equipment, infrastructure, material, home appliance and electrical, display, electronic device, medical, packaging, and consumer/personal care industries. Nitto Denko Corporation was incorporated in 1918 and is headquartered in Osaka, Japan.